Meixler Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-400
| Closed | -$254K | – | 104 |
|
|
2025
Q1 | $254K | Sell |
400
-7
| -2% | -$4.44K | 0.18% | 82 |
|
|
2024
Q4 | $290K | Sell |
407
-9
| -2% | -$6.41K | 0.21% | 80 |
|
|
2024
Q3 | $437K | Sell |
416
-4
| -1% | -$4.21K | 0.32% | 57 |
|
|
2024
Q2 | $441K | Sell |
420
-5
| -1% | -$5.26K | 0.34% | 49 |
|
|
2024
Q1 | $409K | Sell |
425
-1
| -0.2% | -$962 | 0.31% | 55 |
|
|
2023
Q4 | $374K | Sell |
426
-27
| -6% | -$23.7K | 0.31% | 54 |
|
|
2023
Q3 | $373K | Sell |
453
-20
| -4% | -$16.5K | 0.33% | 53 |
|
|
2023
Q2 | $340K | Sell |
473
-5
| -1% | -$3.59K | 0.31% | 58 |
|
|
2023
Q1 | $393K | Sell |
478
-26
| -5% | -$21.4K | 0.38% | 48 |
|
|
2022
Q4 | $364K | Sell |
504
-95
| -16% | -$68.5K | 0.36% | 52 |
|
|
2022
Q3 | $413K | Sell |
599
-17
| -3% | -$11.7K | 0.48% | 41 |
|
|
2022
Q2 | $364K | Buy |
616
+39
| +7% | +$23K | 0.42% | 45 |
|
|
2022
Q1 | $403K | Buy |
577
+115
| +25% | +$80.3K | 0.39% | 52 |
|
|
2021
Q4 | $292K | Buy |
+462
| New | +$292K | 0.3% | 57 |
|